Download PDF
Semin intervent Radiol 2017; 34(04): 337-342
DOI: 10.1055/s-0037-1608704
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Symptomatic Fluid Drainage: Tunneled Peritoneal and Pleural Catheters

Tony Ha
1   Division of Interventional Radiology, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, New York
,
David C. Madoff
2   Department of Radiology, Division of Interventional Radiology, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, New York
,
David Li
2   Department of Radiology, Division of Interventional Radiology, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, New York
› Author Affiliations
Further Information

Publication History

Publication Date:
14 December 2017 (online)

Also available at
    Permissions and Reprints

Abstract

Malignant ascites and pleural effusion are significant contributors to patient symptoms such as shortness of breath, abdominal distension, and nausea in the setting of cancer. There are numerous methods employed to control such symptoms such as serial drainages, pleurodesis, and tunneled drainage catheters. Tunneled drainage catheters are a safe, effective, and a minimally invasive procedure to palliate the symptoms of malignant ascites and pleural effusion.

Keywords

malignant ascites - malignant pleural effusion - tunneled drainage catheter - tunneled peritoneal catheter - tunneled pleural catheter
 

  • References

  • 1 Garrison RN, Kaelin LD, Galloway RH, Heuser LS. Malignant ascites. Clinical and experimental observations. Ann Surg 1986; 203 (06) 644-651
    CrossrefPubMedGoogle Scholar
  • 2 Tapping CR, Ling L, Razack A. PleurX drain use in the management of malignant ascites: safety, complications, long-term patency and factors predictive of success. Br J Radiol 2012; 85 (1013): 623-628
    CrossrefPubMedGoogle Scholar
  • 3 Parsons SL, Lang MW, Steele RJ. Malignant ascites: a 2-year review from a teaching hospital. Eur J Surg Oncol 1996; 22 (03) 237-239
    CrossrefPubMedGoogle Scholar
  • 4 Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol 2007; 18 (05) 945-949
    CrossrefPubMedGoogle Scholar
  • 5 Lacy JH, Wieman TJ, Shively EH. Management of malignant ascites. Surg Gynecol Obstet 1984; 159 (04) 397-412
    PubMedGoogle Scholar
  • 6 Yoneda KY, Mathur PN, Gasparini S. The evolving role of interventional pulmonary in the interdisciplinary approach to the staging and management of lung cancer. Part III: diagnosis and management of malignant pleural effusions. Clin Lung Cancer 2007; 8 (09) 535-547
    CrossrefPubMedGoogle Scholar
  • 7 Macdonald R, Kirwan J, Roberts S, Gray D, Allsopp L, Green J. Ovarian cancer and ascites: a questionnaire on current management in the United kingdom. J Palliat Med 2006; 9 (06) 1264-1270
    CrossrefPubMedGoogle Scholar
  • 8 McNamara P. Paracentesis--an effective method of symptom control in the palliative care setting?. Palliat Med 2000; 14 (01) 62-64
    CrossrefPubMedGoogle Scholar
  • 9 White MA, Agle SC, Padia RK, Zervos EE. Denver peritoneovenous shunts for the management of malignant ascites: a review of the literature in the post LeVeen Era. Am Surg 2011; 77 (08) 1070-1075
    CrossrefPubMedGoogle Scholar
  • 10 Chung M, Kozuch P. Treatment of malignant ascites. Curr Treat Options Oncol 2008; 9 (2-3): 215-233
    CrossrefPubMedGoogle Scholar
  • 11 Smith EM, Jayson GC. The current and future management of malignant ascites. Clin Oncol (R Coll Radiol) 2003; 15 (02) 59-72
    CrossrefPubMedGoogle Scholar
  • 12 Becker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment. Eur J Cancer 2006; 42 (05) 589-597
    CrossrefPubMedGoogle Scholar
  • 13 Heffner JE, Klein JS. Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc 2008; 83 (02) 235-250
    CrossrefPubMedGoogle Scholar
  • 14 Marel M, Zrůstová M, Stasný B, Light RW. The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia. Chest 1993; 104 (05) 1486-1489
    CrossrefPubMedGoogle Scholar
  • 15 Stathopoulos GT, Kalomenidis I. Malignant pleural effusion: tumor-host interactions unleashed. Am J Respir Crit Care Med 2012; 186 (06) 487-492
    CrossrefPubMedGoogle Scholar
  • 16 Zarogoulidis K, Zarogoulidis P, Darwiche K. , et al. Malignant pleural effusion and algorithm management. J Thorac Dis 2013; 5 (Suppl. 04) S413-S419
    PubMedGoogle Scholar
  • 17 Villanueva AG, Gray Jr AW, Shahian DM, Williamson WA, Beamis Jr JF. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 1994; 49 (01) 23-25
    CrossrefPubMedGoogle Scholar
  • 18 Davies HE, Mishra EK, Kahan BC. , et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA 2012; 307 (22) 2383-2389
    CrossrefPubMedGoogle Scholar
  • 19 Fry WA, Khandekar JD. Parietal pleurectomy for malignant pleural effusion. Ann Surg Oncol 1995; 2 (02) 160-164
    CrossrefPubMedGoogle Scholar
  • 20 Rosenberg S, Courtney A, Nemcek Jr AA, Omary RA. Comparison of percutaneous management techniques for recurrent malignant ascites. J Vasc Interv Radiol 2004; 15 (10) 1129-1131
    CrossrefPubMedGoogle Scholar
  • 21 Richard III HM, Coldwell DM, Boyd-Kranis RL, Murthy R, Van Echo DA. Pleurx tunneled catheter in the management of malignant ascites. J Vasc Interv Radiol 2001; 12 (03) 373-375
    CrossrefPubMedGoogle Scholar
  • 22 O'Neill MJ, Weissleder R, Gervais DA, Hahn PF, Mueller PR. Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. AJR Am J Roentgenol 2001; 177 (03) 615-618
    CrossrefPubMedGoogle Scholar
  • 23 Barnett TD, Rubins J. Placement of a permanent tunneled peritoneal drainage catheter for palliation of malignant ascites: a simplified percutaneous approach. J Vasc Interv Radiol 2002; 13 (04) 379-383
    CrossrefPubMedGoogle Scholar
  • 24 Courtney A, Nemcek Jr AA, Rosenberg S, Tutton S, Darcy M, Gordon G. Prospective evaluation of the PleurX catheter when used to treat recurrent ascites associated with malignancy. J Vasc Interv Radiol 2008; 19 (12) 1723-1731
    CrossrefPubMedGoogle Scholar
  • 25 Gilbert CR, Lee HJ, Skalski JH. , et al. The use of indwelling tunneled pleural catheters for recurrent pleural effusions in patients with hematologic malignancies: a multicenter study. Chest 2015; 148 (03) 752-758
    CrossrefPubMedGoogle Scholar
  • 26 Lungren MP, Kim CY, Stewart JK, Smith TP, Miller MJ. Tunneled peritoneal drainage catheter placement for refractory ascites: single-center experience in 188 patients. J Vasc Interv Radiol 2013; 24 (09) 1303-1308
    CrossrefPubMedGoogle Scholar
  • 27 Monsky WL, Yoneda KY, MacMillan J. , et al. Peritoneal and pleural ports for management of refractory ascites and pleural effusions: assessment of impact on patient quality of life and hospice/home nursing care. J Palliat Med 2009; 12 (09) 811-817
    CrossrefPubMedGoogle Scholar
  • 28 Wilshire CL, Louie BE, Aye RW, Farivar AS, Vallières E, Gorden JA. Safety and efficacy of fibrinolytic therapy in restoring function of an obstructed tunneled pleural catheter. Ann Am Thorac Soc 2015; 12 (09) 1317-1322
    CrossrefPubMedGoogle Scholar
  • 29 CareFusion. PleurX Peritoneal Catheter Kit [Instructions for Use]. McGaw Park, IL: CareFusion; 2011
    Google Scholar
  • 30 Bard Access Systems, Inc. Aspira Peritoneal Drainage Catheter [Instructions for Use]. Salt Lake City, UT: Bard Access Systems, Inc.; 2012
    Google Scholar
  • 31 Belfort MA, Stevens PJ, DeHaek K, Soeters R, Krige JE. A new approach to the management of malignant ascites; a permanently implanted abdominal drain. Eur J Surg Oncol 1990; 16 (01) 47-53
    PubMedGoogle Scholar
  • 32 Bui CD, Martin CJ, Currow DC. Case report; effective community palliation of intractable malignant ascites with a permanently implanted abdominal drain. J Palliat Med 1999; 2 (03) 319-321
    CrossrefPubMedGoogle Scholar
  • 33 Sabatelli FW, Glassman ML, Kerns SR, Hawkins Jr IF. Permanent indwelling peritoneal access device for the management of malignant ascites. Cardiovasc Intervent Radiol 1994; 17 (05) 292-294
    CrossrefPubMedGoogle Scholar
  • 34 Mercadante S, Intravaia G, Ferrera P, Villari P, David F. Peritoneal catheter for continuous drainage of ascites in advanced cancer patients. Support Care Cancer 2008; 16 (08) 975-978
    CrossrefPubMedGoogle Scholar
  • 35 Qu C, Xing M, Ghodadra A, McCluskey KM, Santos E, Kim HS. The impact of tunneled catheters for ascites and peritoneal carcinomatosis on patient rehospitalizations. Cardiovasc Intervent Radiol 2016; 39 (05) 711-716
    CrossrefPubMedGoogle Scholar
  • 36 Solbach P, Honer Zu Siederdissen C, Taubert R. , et al. Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesis. Eur J Gastroenterol Hepatol 2017; 29 (05) 539-546
    CrossrefPubMedGoogle Scholar
  • 37 Maleux G, Indesteege I, Laenen A, Verslype C, Vergote I, Prenen H. Tenckhoff tunneled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome. Radiol Oncol 2016; 50 (02) 197-203
    PubMedGoogle Scholar
  • 38 Suzuki K, Servais EL, Rizk NP. , et al. Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters. J Thorac Oncol 2011; 6 (04) 762-767
    CrossrefPubMedGoogle Scholar
  • 39 Freeman RK, Ascioti AJ, Mahidhara RS. A propensity-matched comparison of pleurodesis or tunneled pleural catheter in patients undergoing diagnostic thoracoscopy for malignancy. Ann Thorac Surg 2013; 96 (01) 259-263 , discussion 263–264
    CrossrefPubMedGoogle Scholar
  • 40 Hunt BM, Farivar AS, Vallières E. , et al. Thoracoscopic talc versus tunneled pleural catheters for palliation of malignant pleural effusions. Ann Thorac Surg 2012; 94 (04) 1053-1057 , discussion 1057–1059
    CrossrefPubMedGoogle Scholar
  • 41 Thornton RH, Miller Z, Covey AM. , et al. Tunneled pleural catheters for treatment of recurrent malignant pleural effusion following failed pleurodesis. J Vasc Interv Radiol 2010; 21 (05) 696-700
    CrossrefPubMedGoogle Scholar
  • 42 Wahidi MM, Reddy C, Yarmus L. , et al. Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions - The ASAP Trial. Am J Respir Crit Care Med 2017; 195 (08) 1050-1057
    CrossrefPubMedGoogle Scholar
  • 43 Reddy C, Ernst A, Lamb C, Feller-Kopman D. Rapid pleurodesis for malignant pleural effusions: a pilot study. Chest 2011; 139 (06) 1419-1423
    CrossrefPubMedGoogle Scholar
  • 44 Bohn KA, Ray Jr CE. Repeat large-volume paracentesis versus tunneled peritoneal catheter placement for malignant ascites: a cost-minimization study. AJR Am J Roentgenol 2015; 205 (05) 1126-1134
    CrossrefPubMedGoogle Scholar